Prior Auth Required

01600 - 3

This procedure appears on the selected insurer prior authorization source.

Check another codeExplore policy data
Prior authorizationPrior Auth Required
Procedure / Service3
Procedure / Service Description

Updated Accessed - aspects. Ann Transl Med. 2019;7(13)284. doi:10.21037/atm.2019.07.24 Dhillon S. Avalglucosidase alfa: first approval. Drugs. 2021;81:1803-1809. doi:10.1007/s40265-021- 10/2021 11/2023 01600-3 Nexviaxyme Clinical Trial Information: https://clinicaltrials.gov/ct2/show/study/NCT02782741 09/2021 11/2023 Nexviaxyme Clinical Trial Information: https://clinicaltrials.gov/ct2/show/study/NCT03019406 11/2021 11/2023

Likely documents
  • Confirm benefit details
  • Submit clinical notes if requested by the plan
Next actions
  • Confirm the current plan policy before submission.
  • Use the insurer authorization workflow for this listed code.